These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dopaminergic gene polymorphisms and cognitive function in a north Indian schizophrenia cohort. Kukshal P; Kodavali VC; Srivastava V; Wood J; McClain L; Bhatia T; Bhagwat AM; Deshpande SN; Nimgaonkar VL; Thelma BK J Psychiatr Res; 2013 Nov; 47(11):1615-22. PubMed ID: 23932573 [TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study. Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158 [TBL] [Abstract][Full Text] [Related]
4. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol. Zivković M; Mihaljević-Peles A; Bozina N; Sagud M; Nikolac-Perkovic M; Vuksan-Cusa B; Muck-Seler D J Clin Psychopharmacol; 2013 Oct; 33(5):593-9. PubMed ID: 23963056 [TBL] [Abstract][Full Text] [Related]
5. Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia: genetic influence on dopamine transmission. Loch AA; van de Bilt MT; Bio DS; Prado CM; de Sousa RT; Valiengo LL; Moreno RA; Zanetti MV; Gattaz WF Braz J Psychiatry; 2015; 37(3):235-41. PubMed ID: 26376054 [TBL] [Abstract][Full Text] [Related]
6. Influence of Dopamine-Related Genes on Neurobehavioral Recovery after Traumatic Brain Injury during Early Childhood. Treble-Barna A; Wade SL; Martin LJ; Pilipenko V; Yeates KO; Taylor HG; Kurowski BG J Neurotrauma; 2017 Jun; 34(11):1919-1931. PubMed ID: 28323555 [TBL] [Abstract][Full Text] [Related]
7. Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain. Purves-Tyson TD; Owens SJ; Rothmond DA; Halliday GM; Double KL; Stevens J; McCrossin T; Shannon Weickert C Transl Psychiatry; 2017 Jan; 7(1):e1003. PubMed ID: 28094812 [TBL] [Abstract][Full Text] [Related]
9. [Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia]. Paweł K; Hauser J; Skibińska M; Szczepankiewicz A; Dmitrzak-Weglarz M; Gorzkowska K; Pawlak J; Czerski PM Psychiatr Pol; 2010; 44(3):405-13. PubMed ID: 20672519 [TBL] [Abstract][Full Text] [Related]
10. Influence of Dopaminergic System Genetic Variation and Lifestyle Factors on Excessive Alcohol Consumption. Celorrio D; Muñoz X; Amiano P; Dorronsoro M; Bujanda L; Sánchez MJ; Molina-Montes E; Navarro C; Chirlaque MD; MaríaHuerta J; Ardanaz E; Barricarte A; Rodriguez L; Duell EJ; Hijona E; Herreros-Villanueva M; Sala N; Alfonso-Sánchez MA; de Pancorbo MM Alcohol Alcohol; 2016 May; 51(3):258-67. PubMed ID: 26447226 [TBL] [Abstract][Full Text] [Related]
11. A Meta-analysis of the Association Between SLC6A3 Gene Polymorphisms and Schizophrenia. Xu FL; Ding M; Wu X; Liu YP; Xia X; Yao J; Wang BJ J Mol Neurosci; 2020 Feb; 70(2):155-166. PubMed ID: 31440993 [TBL] [Abstract][Full Text] [Related]
12. Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms. Gupta M; Chauhan C; Bhatnagar P; Gupta S; Grover S; Singh PK; Purushottam M; Mukherjee O; Jain S; Brahmachari SK; Kukreti R Pharmacogenomics; 2009 Feb; 10(2):277-91. PubMed ID: 19207030 [TBL] [Abstract][Full Text] [Related]
13. Fine-mapping reveals novel alternative splicing of the dopamine transporter. Talkowski ME; McCann KL; Chen M; McClain L; Bamne M; Wood J; Chowdari KV; Watson A; Prasad KM; Kirov G; Georgieva L; Toncheva D; Mansour H; Lewis DA; Owen M; O'Donovan M; Papasaikas P; Sullivan P; Ruderfer D; Yao JK; Leonard S; Thomas P; Miyajima F; Quinn J; Lopez AJ; Nimgaonkar VL Am J Med Genet B Neuropsychiatr Genet; 2010 Dec; 153B(8):1434-47. PubMed ID: 20957647 [TBL] [Abstract][Full Text] [Related]
14. The COMT and DRD3 genes interacted in bipolar I but not bipolar II disorder. Lee SY; Chen SL; Chen SH; Huang SY; Tzeng NS; Chang YH; Wang CL; Lee IH; Yeh TL; Yang YK; Lu RB World J Biol Psychiatry; 2011 Aug; 12(5):385-91. PubMed ID: 20698735 [TBL] [Abstract][Full Text] [Related]
15. Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia. Handoko HY; Nyholt DR; Hayward NK; Nertney DA; Hannah DE; Windus LC; McCormack CM; Smith HJ; Filippich C; James MR; Mowry BJ Mol Psychiatry; 2005 Jun; 10(6):589-97. PubMed ID: 15505638 [TBL] [Abstract][Full Text] [Related]
16. No evidence for association between DRD3 and COMT with schizophrenia in a Malay population. Tee SF; Tang PY; Loh HC Genet Mol Res; 2011 Aug; 10(3):1850-5. PubMed ID: 21948748 [TBL] [Abstract][Full Text] [Related]
17. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Nicodemus KK; Kolachana BS; Vakkalanka R; Straub RE; Giegling I; Egan MF; Rujescu D; Weinberger DR Hum Genet; 2007 Feb; 120(6):889-906. PubMed ID: 17006672 [TBL] [Abstract][Full Text] [Related]
18. Functional analysis of upstream common polymorphisms of the dopamine transporter gene. Bamne MN; Talkowski ME; Chowdari KV; Nimgaonkar VL Schizophr Bull; 2010 Sep; 36(5):977-82. PubMed ID: 19273584 [TBL] [Abstract][Full Text] [Related]
19. Epistasis between the DAT 3' UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia. Prata DP; Mechelli A; Fu CH; Picchioni M; Toulopoulou T; Bramon E; Walshe M; Murray RM; Collier DA; McGuire P Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13600-5. PubMed ID: 19666577 [TBL] [Abstract][Full Text] [Related]